Aspirin Cuts Colon Cancer Risk, Harvard Medical School Study Suggests
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Aspirin’s benefit in thwarting colon cancer is driven by a gene mutation that makes tumor cells less sensitive to the drug’s effects, according to a study that may lead to personalized prevention strategies. Developing colon cancer with a mutation of the gene BRAF was similar for both regular aspirin users and non-users, according to research published today in the Journal of the American Medical Association. Regular aspirin users had a 27 percent reduced risk of developing cancer without the mutation compared with those who didn’t regularly take the drug, the study found.
Hey, check out all the research scientist jobs. Post your resume today!
Aspirin’s benefit in thwarting colon cancer is driven by a gene mutation that makes tumor cells less sensitive to the drug’s effects, according to a study that may lead to personalized prevention strategies. Developing colon cancer with a mutation of the gene BRAF was similar for both regular aspirin users and non-users, according to research published today in the Journal of the American Medical Association. Regular aspirin users had a 27 percent reduced risk of developing cancer without the mutation compared with those who didn’t regularly take the drug, the study found.
Hey, check out all the research scientist jobs. Post your resume today!